503 related articles for article (PubMed ID: 11707586)
1. Distinction between signaling mechanisms in lipid rafts vs. caveolae.
Sowa G; Pypaert M; Sessa WC
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):14072-7. PubMed ID: 11707586
[TBL] [Abstract][Full Text] [Related]
2. Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis.
Sonveaux P; Martinive P; DeWever J; Batova Z; Daneau G; Pelat M; Ghisdal P; Grégoire V; Dessy C; Balligand JL; Feron O
Circ Res; 2004 Jul; 95(2):154-61. PubMed ID: 15205364
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta receptors localize to caveolae and regulate endothelial nitric oxide synthase in normal human endothelial cells.
Schwartz EA; Reaven E; Topper JN; Tsao PS
Biochem J; 2005 Aug; 390(Pt 1):199-206. PubMed ID: 15819614
[TBL] [Abstract][Full Text] [Related]
4. The calcium channel blocker amlodipine promotes the unclamping of eNOS from caveolin in endothelial cells.
Batova S; DeWever J; Godfraind T; Balligand JL; Dessy C; Feron O
Cardiovasc Res; 2006 Aug; 71(3):478-85. PubMed ID: 16814758
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide inhibition of adenylyl cyclase type 6 activity is dependent upon lipid rafts and caveolin signaling complexes.
Ostrom RS; Bundey RA; Insel PA
J Biol Chem; 2004 May; 279(19):19846-53. PubMed ID: 15007069
[TBL] [Abstract][Full Text] [Related]
6. Caveolins, caveolae, and lipid rafts in cellular transport, signaling, and disease.
Quest AF; Leyton L; Párraga M
Biochem Cell Biol; 2004 Feb; 82(1):129-44. PubMed ID: 15052333
[TBL] [Abstract][Full Text] [Related]
7. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities.
Razani B; Engelman JA; Wang XB; Schubert W; Zhang XL; Marks CB; Macaluso F; Russell RG; Li M; Pestell RG; Di Vizio D; Hou H; Kneitz B; Lagaud G; Christ GJ; Edelmann W; Lisanti MP
J Biol Chem; 2001 Oct; 276(41):38121-38. PubMed ID: 11457855
[TBL] [Abstract][Full Text] [Related]
8. Spatial segregation of transport and signalling functions between human endothelial caveolae and lipid raft proteomes.
Sprenger RR; Fontijn RD; van Marle J; Pannekoek H; Horrevoets AJ
Biochem J; 2006 Dec; 400(3):401-10. PubMed ID: 16886909
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide attenuates signal transduction: possible role in dissociating caveolin-1 scaffold.
Li H; Brodsky S; Basco M; Romanov V; De Angelis DA; Goligorsky MS
Circ Res; 2001 Feb; 88(2):229-36. PubMed ID: 11157677
[TBL] [Abstract][Full Text] [Related]
10. Methods for the study of signaling molecules in membrane lipid rafts and caveolae.
Ostrom RS; Insel PA
Methods Mol Biol; 2006; 332():181-91. PubMed ID: 16878693
[TBL] [Abstract][Full Text] [Related]
11. Opposing effects of reactive oxygen species and cholesterol on endothelial nitric oxide synthase and endothelial cell caveolae.
Peterson TE; Poppa V; Ueba H; Wu A; Yan C; Berk BC
Circ Res; 1999 Jul; 85(1):29-37. PubMed ID: 10400908
[TBL] [Abstract][Full Text] [Related]
12. Microtubules and actin microfilaments regulate lipid raft/caveolae localization of adenylyl cyclase signaling components.
Head BP; Patel HH; Roth DM; Murray F; Swaney JS; Niesman IR; Farquhar MG; Insel PA
J Biol Chem; 2006 Sep; 281(36):26391-9. PubMed ID: 16818493
[TBL] [Abstract][Full Text] [Related]
13. Agonist-modulated targeting of the EDG-1 receptor to plasmalemmal caveolae. eNOS activation by sphingosine 1-phosphate and the role of caveolin-1 in sphingolipid signal transduction.
Igarashi J; Michel T
J Biol Chem; 2000 Oct; 275(41):32363-70. PubMed ID: 10921915
[TBL] [Abstract][Full Text] [Related]
14. The scaffolding domain of caveolin 2 is responsible for its Golgi localization in Caco-2 cells.
Breuza L; Corby S; Arsanto JP; Delgrossi MH; Scheiffele P; Le Bivic A
J Cell Sci; 2002 Dec; 115(Pt 23):4457-67. PubMed ID: 12414992
[TBL] [Abstract][Full Text] [Related]
15. Dynamic association of nitric oxide downstream signaling molecules with endothelial caveolin-1 in rat aorta.
Linder AE; McCluskey LP; Cole KR; Lanning KM; Webb RC
J Pharmacol Exp Ther; 2005 Jul; 314(1):9-15. PubMed ID: 15778264
[TBL] [Abstract][Full Text] [Related]
16. Caveolae and caveolins in the cardiovascular system.
Gratton JP; Bernatchez P; Sessa WC
Circ Res; 2004 Jun; 94(11):1408-17. PubMed ID: 15192036
[TBL] [Abstract][Full Text] [Related]
17. Caveolae: a once-elusive structure gets some respect.
Marx J
Science; 2001 Nov; 294(5548):1862-5. PubMed ID: 11729300
[No Abstract] [Full Text] [Related]
18. Ovine caveolin-1: cDNA cloning, E. coli expression, and association with endothelial nitric oxide synthase.
Chen D; Zangl AL; Zhao Q; Markley JL; Zheng J; Bird IM; Magness RR
Mol Cell Endocrinol; 2001 Apr; 175(1-2):41-56. PubMed ID: 11325515
[TBL] [Abstract][Full Text] [Related]
19. Lipid rafts in health and disease.
Michel V; Bakovic M
Biol Cell; 2007 Mar; 99(3):129-40. PubMed ID: 17064251
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor alpha and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae.
Chambliss KL; Yuhanna IS; Mineo C; Liu P; German Z; Sherman TS; Mendelsohn ME; Anderson RG; Shaul PW
Circ Res; 2000 Nov; 87(11):E44-52. PubMed ID: 11090554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
